Reuters US Business

By Bhanvi Satija and Siddhi Mahatole (Reuters) -Sarepta Therapeutics shares snapped a three-day losing streak on Tuesday, as analysts said resumption of U.S. shipments for its muscular gene therapy soothes immediate concerns about liquidity and the therapy’s withdrawal from the market. The company said on Monday it would resume shipments of Elevidys — approved in …

Sarepta shares rebound after shipments of gene therapy Elevidys resume in US Read More »

WASHINGTON (Reuters) -Recent actions by the U.S. Consumer Financial Protection Bureau have reversed or jeopardized more than $360 million in compensation paid to consumers allegedly harmed by financial companies, an analysis by consumer groups said on Tuesday. The compensation relates to allegations of predatory practices by lenders, student loan servicers, money transfer businesses and others pursued …

More than $360 million in CFPB compensation ‘at risk,’ say US consumer groups Read More »

By Abhinav Parmar and Lisa Baertlein (Reuters) -United Parcel Service posted quarterly profit marginally below estimates on Tuesday and again declined to issue annual revenue and margin forecasts, deepening concerns that changing U.S. trade policy is weighing on the delivery giant. Shares in the world’s largest parcel delivery firm fell more than 9% to $92.16 …

UPS profit lower than expected as US trade policy shifts Read More »

By Sriparna Roy and Sneha S K (Reuters) -UnitedHealth Group provided a full-year profit forecast on Tuesday after suspending its prior outlook in May, revealing billions of additional costs the company will face in the upcoming quarters.   The health insurer projected full-year adjusted earnings per share of at least $16, well short of analysts’ …

UnitedHealth signals prolonged pain with new, far lower profit forecast, shares fall Read More »

By Jessica DiNapoli and Juveria Tabassum (Reuters) -Procter & Gamble on Tuesday forecast annual results largely below estimates and said it would raise prices on some products in the U.S., a day after naming insider Shailesh Jejurikar as CEO to steer it through tariff uncertainty. Economic volatility and “consumer anxiety” stemming from U.S. President Donald …

Procter & Gamble hikes US prices to blunt tariff hit as CEO transition looms Read More »

By Aishwarya Jain and Doyinsola Oladipo (Reuters) -JetBlue Airways on Tuesday posted an adjusted loss for the second quarter that was smaller than Wall Street expectations, helped by cost cutting measures and recovering demand for travel in the U.S. Shares of the carrier shot up nearly 12% in early morning trading as the company also said …

JetBlue posts smaller-than-expected loss as U.S. demand recovers Read More »